TY - JOUR AU - Baldo, B. A. AU - Pham, N. H. PY - 2013 DA - 2013// TI - Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch JO - Cancer Metastasis Rev VL - 32 UR - https://doi.org/10.1007/s10555-013-9447-3 DO - 10.1007/s10555-013-9447-3 ID - Baldo2013 ER - TY - JOUR AU - Reyes-Habito, C. M. AU - Roh, E. K. PY - 2014 DA - 2014// TI - Cutaneous reactions to chemotherapeutic drugs and targeted therapies for cancer: part I. conventional chemotherapeutic drugs JO - J Am Acad Dermatol VL - 71 ID - Reyes-Habito2014 ER - TY - JOUR AU - Reyes-Habito, C. M. AU - Roh, E. K. PY - 2014 DA - 2014// TI - Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer: part II. Targeted therapy JO - J Am Acad Dermatol VL - 71 ID - Reyes-Habito2014 ER - TY - JOUR AU - Payne, A. S. AU - James, W. D. AU - Weiss, R. B. PY - 2006 DA - 2006// TI - Dermatologic toxicity of chemotherapeutic agents JO - Semin Oncol VL - 33 UR - https://doi.org/10.1053/j.seminoncol.2005.11.004 DO - 10.1053/j.seminoncol.2005.11.004 ID - Payne2006 ER - TY - JOUR AU - Zhang, X. AU - Ran, Y. G. AU - Wang, K. J. PY - 2016 DA - 2016// TI - Risk of severe rash in cancer patients treated with EGFR tyrosine kinase inhibitors: a systematic review and meta-analysis JO - Future Oncol VL - 12 UR - https://doi.org/10.2217/fon-2016-0180 DO - 10.2217/fon-2016-0180 ID - Zhang2016 ER - TY - JOUR AU - Wollenberg, A. AU - Kroth, J. AU - Hauschild, A. PY - 2010 DA - 2010// TI - Cutaneous side effects of EGFR inhibitors--appearance and management JO - Dtsch Med Wochenschr VL - 135 UR - https://doi.org/10.1055/s-0029-1244831 DO - 10.1055/s-0029-1244831 ID - Wollenberg2010 ER - TY - JOUR AU - Miller, K. K. AU - Gorcey, L. AU - Mclellan, B. N. PY - 2014 DA - 2014// TI - Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management JO - J Am Acad Dermatol VL - 71 UR - https://doi.org/10.1016/j.jaad.2014.03.019 DO - 10.1016/j.jaad.2014.03.019 ID - Miller2014 ER - TY - JOUR AU - Koukakis, R. AU - Gatta, F. AU - Hechmati, G. AU - Siena, S. PY - 2016 DA - 2016// TI - Skin toxicity and quality of life during treatment with panitumumab for RAS wild-type metastatic colorectal carcinoma: results from three randomised clinical trials JO - Qual Life Res VL - 25 UR - https://doi.org/10.1007/s11136-016-1288-4 DO - 10.1007/s11136-016-1288-4 ID - Koukakis2016 ER - TY - JOUR AU - Macdonald, J. B. AU - Macdonald, B. AU - Golitz, L. E. AU - LoRusso, P. AU - Sekulic, A. PY - 2015 DA - 2015// TI - Cutaneous adverse effects of targeted therapies: part I: inhibitors of the cellular membrane JO - J Am Acad Dermatol VL - 72 UR - https://doi.org/10.1016/j.jaad.2014.07.032 DO - 10.1016/j.jaad.2014.07.032 ID - Macdonald2015 ER - TY - BOOK PY - 1990 DA - 1990// TI - Clinical practice guidelines: directions for a new program PB - National Academy Press CY - Washington ID - ref10 ER - TY - JOUR AU - Shaneyfelt, T. M. AU - Mayo-Smith, M. F. AU - Rothwangl, J. PY - 1999 DA - 1999// TI - Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature JO - JAMA. VL - 281 UR - https://doi.org/10.1001/jama.281.20.1900 DO - 10.1001/jama.281.20.1900 ID - Shaneyfelt1999 ER - TY - JOUR AU - Grilli, R. AU - Magrini, N. AU - Penna, A. AU - Mura, G. AU - Liberati, A. PY - 2000 DA - 2000// TI - Practice guidelines developed by specialty societies: the need for a critical appraisal JO - Lancet. VL - 355 UR - https://doi.org/10.1016/S0140-6736(99)02171-6 DO - 10.1016/S0140-6736(99)02171-6 ID - Grilli2000 ER - TY - JOUR AU - Zhang, F. AU - Shen, A. AU - Jin, Y. AU - Qiang, W. PY - 2018 DA - 2018// TI - The management strategies of cancer-associated anorexia: a critical appraisal of systematic reviews JO - BMC Complement Altern Med VL - 18 UR - https://doi.org/10.1186/s12906-018-2304-8 DO - 10.1186/s12906-018-2304-8 ID - Zhang2018 ER - TY - JOUR AU - Jin, Y. AU - Wang, Y. AU - Zhang, Y. PY - 2016 DA - 2016// TI - Nursing practice guidelines in China do need reform: a critical appraisal using the AGREE II instrument JO - Worldviews Evid-Based Nurs VL - 13 UR - https://doi.org/10.1111/wvn.12127 DO - 10.1111/wvn.12127 ID - Jin2016 ER - TY - JOUR AU - Brouwers, M. C. AU - Kho, M. E. AU - Browman, G. P. PY - 2010 DA - 2010// TI - AGREE II: advancing guideline development, reporting, and evaluation in health care JO - Prev Med VL - 51 UR - https://doi.org/10.1016/j.ypmed.2010.08.005 DO - 10.1016/j.ypmed.2010.08.005 ID - Brouwers2010 ER - TY - JOUR AU - Dans, A. L. AU - Dans, L. F. PY - 2010 DA - 2010// TI - Appraising a tool for guideline appraisal (the AGREE II instrument) JO - J Clin Epidemiol VL - 63 UR - https://doi.org/10.1016/j.jclinepi.2010.06.005 DO - 10.1016/j.jclinepi.2010.06.005 ID - Dans2010 ER - TY - JOUR AU - Chiappini, E. AU - Bortone, B. AU - Galli, L. AU - Martino, M. D. PY - 2017 DA - 2017// TI - Guidelines for the symptomatic management of fever in children: systematic review of the literature and quality appraisal with AGREE II JO - BMJ Open VL - 7 UR - https://doi.org/10.1136/bmjopen-2016-015404 DO - 10.1136/bmjopen-2016-015404 ID - Chiappini2017 ER - TY - JOUR AU - Bragge, P. AU - Pattuwage, L. AU - Marshall, S. PY - 2014 DA - 2014// TI - Quality of guidelines for cognitive rehabilitation following traumatic brain injury JO - J Head Trauma Rehab VL - 29 UR - https://doi.org/10.1097/HTR.0000000000000066 DO - 10.1097/HTR.0000000000000066 ID - Bragge2014 ER - TY - JOUR AU - Ríos, E. AU - Serón, P. AU - Lanas, F. AU - Bonfill, X. AU - Quigley, E. M. M. AU - Alonso-Coello, P. PY - 2014 DA - 2014// TI - Evaluation of the quality of clinical practice guidelines for the management of esophageal or gastric variceal bleeding JO - Eur J Gastroen Hepat VL - 26 UR - https://doi.org/10.1097/MEG.0000000000000033 DO - 10.1097/MEG.0000000000000033 ID - Ríos2014 ER - TY - STD TI - National Institute for Health and Care Excellence (NICE). Developing NICE Guidelines: The Manual. London; 2015. ID - ref20 ER - TY - JOUR AU - Lynch, T. J. AU - Kim, E. S. AU - Eaby, B. AU - Garey, J. AU - West, D. P. AU - Lacouture, M. E. PY - 2007 DA - 2007// TI - Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management JO - Oncologist. VL - 12 UR - https://doi.org/10.1634/theoncologist.12-5-610 DO - 10.1634/theoncologist.12-5-610 ID - Lynch2007 ER - TY - JOUR AU - Gridelli, C. AU - Maione, P. AU - Amoroso, D. PY - 2008 DA - 2008// TI - Clinical significance and treatment of skin rash from erlotinib in non-small cell lung cancer patients: results of an experts panel meeting JO - Crit Rev Oncol Hematol VL - 66 UR - https://doi.org/10.1016/j.critrevonc.2007.10.004 DO - 10.1016/j.critrevonc.2007.10.004 ID - Gridelli2008 ER - TY - JOUR AU - Eaby, B. AU - Culkin, A. AU - Lacouture, M. E. PY - 2008 DA - 2008// TI - An interdisciplinary consensus on managing skin reactions associated with human epidermal growth factor receptor inhibitors JO - Clin J Oncol Nurs VL - 12 UR - https://doi.org/10.1188/08.CJON.283-290 DO - 10.1188/08.CJON.283-290 ID - Eaby2008 ER - TY - JOUR AU - Thatcher, N. AU - Nicolson, M. AU - Groves, R. W. PY - 2009 DA - 2009// TI - Expert consensus on the Management of Erlotinib-Associated Cutaneous Toxicity in the U.K JO - Oncologist. VL - 14 ID - Thatcher2009 ER - TY - JOUR AU - Kollmannsberger, C. AU - Bjarnason, G. AU - Burnett, P. PY - 2011 DA - 2011// TI - Sunitinib in metastatic renal cell carcinoma: recommendations for management of noncardiovascular toxicities JO - Oncologist. VL - 16 UR - https://doi.org/10.1634/theoncologist.2010-0263 DO - 10.1634/theoncologist.2010-0263 ID - Kollmannsberger2011 ER - TY - JOUR AU - Gutzmer, R. AU - Becker, J. C. AU - Enk, A. PY - 2011 DA - 2011// TI - Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician JO - J Dtsch Dermatol Ges VL - 9 ID - Gutzmer2011 ER - TY - JOUR AU - Lacouture, M. E. AU - Anadkat, M. J. AU - Bensadoun, R. PY - 2011 DA - 2011// TI - Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities JO - Support Care Cancer VL - 19 UR - https://doi.org/10.1007/s00520-011-1197-6 DO - 10.1007/s00520-011-1197-6 ID - Lacouture2011 ER - TY - JOUR AU - Potthoff, K. AU - Hofheinz, R. AU - Hassel, J. C. PY - 2011 DA - 2011// TI - Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdq387 DO - 10.1093/annonc/mdq387 ID - Potthoff2011 ER - TY - JOUR AU - Pinto, C. AU - Barone, C. A. AU - Girolomoni, G. PY - 2011 DA - 2011// TI - Management of Skin Toxicity Associated with Cetuximab treatment in combination with chemotherapy or radiotherapy JO - Oncologist. VL - 16 UR - https://doi.org/10.1634/theoncologist.2010-0298 DO - 10.1634/theoncologist.2010-0298 ID - Pinto2011 ER - TY - JOUR AU - Reguiai, Z. AU - Bachet, J. B. AU - Bachmeyer, C. PY - 2012 DA - 2012// TI - Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm JO - Support Care Cancer VL - 20 UR - https://doi.org/10.1007/s00520-012-1451-6 DO - 10.1007/s00520-012-1451-6 ID - Reguiai2012 ER - TY - BOOK PY - 2012 DA - 2012// TI - Prevention and treatment of rash in patients treated with EGFR inhibitor therapies PB - CancerControl Alberta CY - Edmonton ID - ref31 ER - TY - JOUR AU - Bensadoun, R. J. AU - Humbert, P. AU - Krutman, J. PY - 2013 DA - 2013// TI - Daily baseline skin care in the prevention, treatment, and supportive care of skin toxicity in oncology patients: recommendations from a multinational expert panel JO - Cancer Manag Res VL - 5 UR - https://doi.org/10.2147/CMAR.S52256 DO - 10.2147/CMAR.S52256 ID - Bensadoun2013 ER - TY - JOUR AU - Arriola, E. AU - Reguart, N. AU - Artal, A. PY - 2015 DA - 2015// TI - Management of the adverse events of afatinib: a consensus of the recommendations of the Spanish expert panel JO - Future Oncol VL - 11 UR - https://doi.org/10.2217/fon.14.214 DO - 10.2217/fon.14.214 ID - Arriola2015 ER - TY - JOUR AU - Califano, R. AU - Tariq, N. AU - Compton, S. AU - Fitzgerald, D. A. AU - Harwood, C. A. PY - 2015 DA - 2015// TI - Expert consensus on the Management of Adverse Events from EGFR tyrosine kinase inhibitors in the UK JO - Drugs VL - 75 UR - https://doi.org/10.1007/s40265-015-0434-6 DO - 10.1007/s40265-015-0434-6 ID - Califano2015 ER - TY - JOUR AU - Parikh, P. AU - Prabhash, K. AU - Naik, R. PY - 2016 DA - 2016// TI - Practical recommendation for rash and diarrhea management in Indian patients treated with tyrosine kinase inhibitors for the treatment of non-small cell lung cancer JO - Indian J Cancer VL - 53 UR - https://doi.org/10.4103/0019-509X.180863 DO - 10.4103/0019-509X.180863 ID - Parikh2016 ER - TY - JOUR AU - Pinto, C. AU - Barone, C. A. AU - Girolomoni, G. PY - 2016 DA - 2016// TI - Management of Skin Reactions during Cetuximab Treatment in association with chemotherapy or radiotherapy JO - Am J Clin Oncol VL - 39 UR - https://doi.org/10.1097/COC.0000000000000291 DO - 10.1097/COC.0000000000000291 ID - Pinto2016 ER - TY - JOUR AU - Czupryn, M. AU - Cisneros, J. PY - 2017 DA - 2017// TI - BRAF/MEK inhibitor therapy: consensus statement from the Faculty of the Melanoma Nursing Initiative on managing adverse events and potential drug interactions[J] JO - Clin J Oncol Nurs VL - 21 ID - Czupryn2017 ER - TY - JOUR AU - Chu, C. Y. AU - Chen, K. Y. AU - Chang, J. AU - Wei, Y. F. AU - Lee, C. H. PY - 2017 DA - 2017// TI - Taiwanese dermatological association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities[J] JO - J Formos Med Assoc VL - 116 UR - https://doi.org/10.1016/j.jfma.2017.03.001 DO - 10.1016/j.jfma.2017.03.001 ID - Chu2017 ER - TY - STD TI - Oncology Nursing Society. Putting Evidence into Practice: Skin Reactions; 2017. https://www.ons.org/practice-resources/pep/skin-reactions. UR - https://www.ons.org/practice-resources/pep/skin-reactions ID - ref39 ER - TY - JOUR AU - Shekelle, P. G. PY - 2018 DA - 2018// TI - Clinical practice guidelines What’s next? JO - JAMA VL - 320 UR - https://doi.org/10.1001/jama.2018.9660 DO - 10.1001/jama.2018.9660 ID - Shekelle2018 ER - TY - JOUR AU - Brouwers, M. C. AU - Kho, M. E. AU - Browman, G. P. PY - 2010 DA - 2010// TI - Development of the AGREE II, part 2: assessment of validity of items and tools to support application JO - CMAJ. VL - 182 UR - https://doi.org/10.1503/cmaj.091716 DO - 10.1503/cmaj.091716 ID - Brouwers2010 ER - TY - JOUR AU - Cavazos, J. M. AU - Naik, A. D. AU - Woofter, A. AU - Abraham, N. S. PY - 2008 DA - 2008// TI - Barriers to physician adherence to nonsteroidal anti-inflammatory drug guidelines: a qualitative study JO - Aliment Pharmacol Ther VL - 28 UR - https://doi.org/10.1111/j.1365-2036.2008.03791.x DO - 10.1111/j.1365-2036.2008.03791.x ID - Cavazos2008 ER - TY - JOUR AU - Cabana, M. D. AU - Rand, C. S. AU - Powe, N. R. PY - 1999 DA - 1999// TI - Why don’t physicians follow clinical practice guidelines? A framework for improvement JO - JAMA VL - 282 UR - https://doi.org/10.1001/jama.282.15.1458 DO - 10.1001/jama.282.15.1458 ID - Cabana1999 ER - TY - JOUR AU - Larenas-Linnemann, D. E. S. AU - Antolín-Amérigo, D. AU - Parisi, C. PY - 2018 DA - 2018// TI - National clinical practice guidelines for allergen immunotherapy: an international assessment applying AGREE-II JO - Allergy. VL - 73 UR - https://doi.org/10.1111/all.13316 DO - 10.1111/all.13316 ID - Larenas-Linnemann2018 ER - TY - JOUR AU - Sox, H. C. PY - 2017 DA - 2017// TI - Conflict of interest in practice guidelines panels JO - JAMA VL - 317 UR - https://doi.org/10.1001/jama.2017.2701 DO - 10.1001/jama.2017.2701 ID - Sox2017 ER - TY - STD TI - About the Updating GuidelinesWorking Group. Guidelines International Network website. http://www.g-i-n.net/working-groups/updating-guidelines/about. Updated April 13, 2016. Accessed 19 Jan 2019. UR - http://www.g-i-n.net/working-groups/updating-guidelines/about ID - ref46 ER - TY - JOUR AU - Grol, R. AU - Cluzeau, F. A. AU - Burgers, J. S. PY - 2003 DA - 2003// TI - Clinical practice guidelines: towards better quality guidelines and increased international collaboration JO - Br J Cancer VL - 89 UR - https://doi.org/10.1038/sj.bjc.6601077 DO - 10.1038/sj.bjc.6601077 ID - Grol2003 ER - TY - JOUR AU - Holmer, H. K. AU - Ogden, L. A. AU - Burda, B. U. AU - Norris, S. L. PY - 2013 DA - 2013// TI - Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0058625 DO - 10.1371/journal.pone.0058625 ID - Holmer2013 ER - TY - JOUR AU - Chen, Y. L. AU - Yang, K. H. AU - Marusic, A. AU - Qaseem, A. AU - Meerpohl, J. J. PY - 2017 DA - 2017// TI - A reporting tool for practice guidelines in health care: the RIGHT statement[J] JO - Ann Intern Med VL - 166 UR - https://doi.org/10.7326/M16-1565 DO - 10.7326/M16-1565 ID - Chen2017 ER -